CAS 1772-03-8
:Galactosamine hydrochloride
- 2-Amino-2-Deoxyhexopyranose Hydrochloride
- 2-Amino-2-deoxy-<span class="text-smallcaps">D</span>-galactose hydrochloride
- 2-Amino-2-deoxy-D-galactopyranose hydrochloride
- 2-ammonio-2-deoxy-alpha-D-galactopyranose
- 2-ammonio-2-deoxy-beta-D-galactopyranose
- <span class="text-smallcaps">D</span>-Galactosamine hydrochloride
- <span class="text-smallcaps">D</span>-Galactose, 2-amino-2-deoxy-, hydrochloride
- <span class="text-smallcaps">D</span>-Galactose, 2-amino-2-deoxy-, hydrochloride (1:1)
- Chondrosamine hydrochloride
- D(+)Galactosamine, HCl
- D-Chondrosamine hydrochloride
- D-Glactosamine Hydrochloride
- Galactosamine hydrochloride
- Galactose, 2-amino-2-deoxy-, hydrochloride, <span class="text-smallcaps">D</span>-
- D(+)Galactosamine hydrochloride
- Galactose, 2-amino-2-deoxy-, hydrochloride, D-
- D-Galactosamine hydrochloride
- D(+)-Galactosamine hydrochloride
- D-Galactose, 2-amino-2-deoxy-, hydrochloride
- D(+)-Galactosamine Hydrochloride
- D-Galactose, 2-amino-2-deoxy-, hydrochloride (1:1)
- D-Galactosamine hydrochloride
- See more synonyms
D-(+)-Galactosamine Hydrochloride
CAS:Formula:C6H13NO5·HClPurity:>98.0%(HPLC)(N)Color and Shape:White to Almost white powder to crystalMolecular weight:215.63Galactosamine Hydrochloride
CAS:Heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C6H13NO5·ClHColor and Shape:PowderMolecular weight:215.05605D-(+)-Galactosamine hydrochloride
CAS:D-(+)-Galactosamine hydrochlorideFormula:C6H13NO5·ClHPurity:98% (nmr) (Typical Value in Batch COA)Color and Shape: white solidMolecular weight:215.63g/molD(+)-Galactosamine hydrochloride
CAS:D(+)-Galactosamine hydrochloridePurity:≥95%Molecular weight:215.63g/molD-(+)-Galactosamine hydrochloride
CAS:Formula:C6H13NO5·HClPurity:≥ 98.0%Color and Shape:White to off-white powderMolecular weight:215.64D(+)-Galactosamine hydrochloride
CAS:D(+)-Galactosamine hydrochloride (D-Galactosamine HCl) hepatotoxicity is associated with endotoxin sensitivity and mediated by lymphoreticular cells in mice.Formula:C6H14ClNO5Purity:99.855% - ≥95%Color and Shape:White PowderMolecular weight:215.63D-Galactosamine, Hydrochloride
CAS:Controlled ProductApplications Specifically inhibits COX-2 by preventing COX-2 N-glycosylation and by increasing COX-2 protein turnover in a proteasome-dependent manner.
References Inoue, H., et al.: J. Biol. Chem., 270, 24965 (1995), Smith, W., et al.: Adv. Immunol., 62, 167 (1996), Nemeth, J., et al.: Biochemistry, 40, 3109 (2001), Tamura, M., et al.: J. Clin. Endocrinol. Metab., 87, 3263 (2002),Formula:C6H13NO5·ClHColor and Shape:NeatMolecular weight:215.63D-Galactosamine hydrochloride
CAS:D-Galactosamine (GalN) is an aldohexose (2-Amino-2-deoxygalactose) in which the hydroxyl group at position 2 is replaced by an amino group (Collins, 2006). Galactosamine (as the N-Acetyl derivative) forms a key part of both N- and O-linked glycoproteins, glycolipids and glycosaminoglycans. Treatment of experimental animals with D-galactosamine / lipopolysaccharide causes lethal liver injury characterized by apoptosis of the hepatocyte and it is used as a laboratory model to study the effect of therapeutic agents (Hirono, 2001).
Formula:C6H14ClNO5Molecular weight:215.63 g/molD-Galactosamine hydrochloride
CAS:D-Galactosamine (GalN) is an aldohexose (2-amino-2-deoxygalactose) in which the hydroxyl group at position 2 is replaced by an amino group (Collins, 2006). Galactosamine (as the N-acetyl derivative) forms a key part of both N- and O-linked glycoproteins, glycolipids and glycosaminoglycans. Treatment of experimental animals with D-galactosamine / lipopolysaccharide causes lethal liver injury characterized by apoptosis of the hepatocyte and it is used as a laboratory model to study the effect of therapeutic agents (Hirono, 2001).
Formula:C6H13NO5·HClPurity:Min. 98 Area-%Color and Shape:White Off-White PowderMolecular weight:215.63 g/molD-Galactosamine hydrochloride - Synthetic origin
CAS:D-Galactosamine (GalN) is an aldohexose (2-Amino-2-deoxygalactose) in which the hydroxyl group at position 2 is replaced by an amino group (Collins, 2006). Galactosamine (as the N-Acetyl derivative) forms a key part of both N- and O-linked glycoproteins, glycolipids and glycosaminoglycans. Treatment of experimental animals with D-galactosamine / lipopolysaccharide causes lethal liver injury characterized by apoptosis of the hepatocyte and it is used as a laboratory model to study the effect of therapeutic agents (Hirono, 2001).Formula:C6H13NO5·HClPurity:Min. 98 Area-%Color and Shape:White PowderMolecular weight:215.63 g/molD-Galactoseamine hydrochloride
CAS:Formula:C6H14ClNO5Purity:97%Color and Shape:CrystallineMolecular weight:215.63D-Galactosamine Hydrochloride extrapure, 98%
CAS:Formula:C6H14ClNO5Purity:min. 98%Color and Shape:White to off white, Crystalline powder, Clear, Colourless to pale yellowMolecular weight:215.63










